PATENT CLAIM ANALYSIS

Application Number: 15959318
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "234200"]

Abstract:
The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

Claim (Index 5):
The method according to  claim 1 , wherein said respiratory disorder is selected from bronchial asthma, bronchitis, allergic rhinitis, adult respiratory syndrome, cystic fibrosis, lung viral infection (influenza), pulmonary hypertension, idiopathic pulmonary fibrosis and chronic obstructive pulmonary diseases (COPD).

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.16216
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13755617', '13120438', '14750019', '13120440', '13734205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8308008694676317
- 35 USC 102 Novelty (BERT): 0.6573438493175972
- Combined Prediction Score: 0.8134551674526282
- Mean Citation Score: 637.4256419999998
- Max Citation Score: 646.59875
- Similarity Product: 601.834898277074

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test